In collaboration with Mangaluru city police, Make a Change Foundation is set to launch the large-scale ‘Nasha Mukta Mangaluru’ (Drug-Free Mangaluru) campaign, featuring a total of 102 programmes aimed ...

Data were shared at the 67th Annual Meeting of the American Society of Hematology (ASH) ORLANDO, Fla.--(BUSINESS WIRE)--December 8, 2025-- Opna Bio, ...

CytoAgents, Inc., a clinical-stage biotechnology company developing CTO1681, a novel, steroid-sparing inhibitor of prostaglandin-mediated inflammation announced today that data from two of its Investi ...

Poster presentation highlights promising results from Phase 1b/2 TENACITY-01 study of CTD402 in T-Cell and myeloid leukemiasFindings underscore ...

BGB-11417-202 ( NCT05479994) is an open-label, phase 2, and a potential registrational study evaluating the efficacy and safety of sonrotoclax in 100 heavily pretreated patients with R/R CLL/SLL. At a ...

Kelonia Therapeutics, Inc., a clinical-stage biotechnology company pioneering in vivo gene delivery, today shared first-in-human data from the ongoing inMMyCARTM study, a Phase 1 clinical trial ...

In a drastic turn of events, Donald Trump is reportedly considering replacing DHS Secretary Kristi Noem with outbound ...

The Supreme Court previously allowed Trump to oust Gwynne Wilcox at the National Labor Relations Board and Cathy Harris at ...

The world is a dangerous place, and it might be scarier than we think. Many people even worry about the fate of our ...

Oral presentation from pooled analyses of the IMerge population suggests that treatment-emergent cytopenias may reflect on-target effects associated with meaningful clinical outcomes, including ...

Incyte today announced updated clinical data from two Phase 1 studies evaluating the safety, tolerability and efficacy of INCA033989, a first-in-class mutant calreticulin (mutCALR)-targeted monoclonal ...

During the 2016 election campaign, Donald Trump infamously asserted, “I could stand in the middle of Fifth Avenue and shoot ...